Pharmaceutical, biotechnology and medical products companies
January 10, 2018

Accenture Report Highlights What Patients Want in New Treatments; Two-Thirds Say: Better Outcomes, Not Brands

NEW YORK; Jan. 10, 2018 When launching new products, pharmaceutical companies should focus more on evidence-based solutions than just the product or brand, according to a new report from Accenture (NYSE: ACN) on product launches in the pharmaceutical industry
January 08, 2018

Nanowear Named Innovation Champion of the Accenture HealthTech Innovation Challenge

SAN FRANCISCO; Jan. 8, 2018 – Nanowear has been named the Innovation Champion of the Accenture (NYSE: ACN) HealthTech Innovation Challenge, which pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
December 20, 2017

Accenture and Roche Collaborate to Enhance Digital Healthcare for Cancer Patients

NEW YORK; Dec. 20, 2017 – Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.
December 11, 2017

Shionogi Signs Strategic Digital Transformation Agreement with Accenture

TOKYO; Dec. 11, 2017 – Accenture (NYSE: ACN) has signed consulting and strategic outsourcing agreements with Shionogi & Co., Ltd. ("Shionogi") and its subsidiary company, Shionogi Digital Science Co., Ltd. ("Shionogi Digital Science”) to help Shionogi with its digital transformation initiative.

 
November 07, 2017

Accenture Launches the Patient Experience Manager to Help Life Sciences Companies Improve Care and Value for Patient Services Programs

NEW YORK; Nov. 7, 2017 – Accenture (NYSE: ACN) has launched the Patient Experience Manager which gives life sciences companies a single view of patient interactions, enabling them to make real time improvements in the patient experience by evaluating and optimizing the effectiveness of each interaction. 
October 03, 2017

Accenture Collaborates with Veeva Systems to Advance Regulatory Information Management for the Life Sciences Industry

NEW YORK; Oct. 3, 2017 – Accenture (NYSE: ACN) today announced it is working with Veeva Systems (NYSE: VEEV), a leader in cloud-based software for the global life sciences industry, to bring Veeva Vault RIM – a transformative regulatory information management solution – to biopharma companies. The collaboration will help enable the industry to bring new medicines to patients faster. 
September 07, 2017

Lack of Awareness Limiting Use of Patient Services, Accenture Research Finds

NEW YORK; Sept. 7, 2017 –  New research from Accenture finds healthcare professionals’ lack of awareness is limiting the usage of patient services (such as adherence programs and remote monitoring) offered by pharmaceutical companies. This is a critical disconnect as patients and pharmaceutical companies primarily rely on healthcare professionals to provide information to their patients on support services. 
August 14, 2017

Accenture Positioned as Leader and Star Performer in Everest Group 2017 Life Sciences Clinical and R&D IT Services Assessment

NEW YORK; Aug. 14, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer in a new Everest Group report on information technology (IT) service providers in the life sciences clinical and R&D industry. 
July 31, 2017

Accenture Positioned as Leader and Star Performer in Everest Group 2017 Life Sciences IT Application Services Assessment

NEW YORK; July 31, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer among 21 providers of life sciences information technology (IT) application services, in the latest Everest Group report: Life Sciences IT Applications Services – Service Provider Landscape with PEAK Matrix™ Assessment 2017. Accenture is positioned above all competitors in life sciences IT application service providers, based on its scale of operations, scope of services, investments in technology, global delivery footprint and buyer satisfaction. 
July 26, 2017

Accenture To Transform Diabetic Patient Care Using Data-driven Analytics Platform

NEW YORK; July 26, 2017 – Accenture (NYSE: ACN) is collaborating with Roche (SIX: RO, ROG; OTCQX: RHHBY) to improve how diabetes care is managed and delivered through the development of a data-driven core analytics platform for Roche’s digital diabetes ecosystem. The platform and ecosystem will seamlessly connect patients, their caregivers and healthcare providers with a suite of new digital health services.